HCQ
Showing 1 - 25 of 293
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
Clarifying Misbeliefs About Hydroxychloroquine:
Not yet recruiting
- Lupus
- Decision-making tool
- Questionnaire
-
Madison, WisconsinUniversity of Wisconsin
Jun 19, 2023
Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)
Withdrawn
- Solid Tumor
- Advanced Breast Cancer
- Abemaciclib
- +6 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))
Recruiting
- Hepatocellular Cancer
- Sorafenib (SOR)
- Hydroxychloroquine (HCQ)
-
San Antonio, TexasUniversity of Texas Health Cancer Center
Sep 16, 2022
Pancreatic Cancer, Advanced Cancer Trial in Boston, Chapel Hill (Hydroxychloroquine Sulfate, LY3214996)
Recruiting
- Pancreatic Cancer
- Advanced Cancer
- Hydroxychloroquine Sulfate
- LY3214996
-
Boston, Massachusetts
- +2 more
Apr 6, 2022
2019 Novel Coronavirus Trial in Amman (HCQ01, standard of care (SOC) for COVID-19)
Not yet recruiting
- 2019 Novel Coronavirus
- HCQ01
- standard of care (SOC) for COVID-19
-
Amman, JordanKing Hussein Cancer Center
Jun 25, 2022
The Clinical Features and Pregnancy Outcomes of RA Patients
Recruiting
- Rheumatoid Arthritis
- Pregnancy Related
- Prednisone
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Dec 6, 2022
COVID-19 Trial in Amman (HCQ & AZ)
Withdrawn
- COVID-19
- HCQ & AZ
-
Amman, JordanKing Hussein Cancer Center
Oct 23, 2021
Ulcerative Colitis (Disorder) Trial in Atlanta, New York (Hydroxychloroquine, Mesalamine)
Recruiting
- Ulcerative Colitis (Disorder)
-
Atlanta, Georgia
- +1 more
Sep 26, 2022
APS Secondary to SLE
Recruiting
- Antiphospholipid Syndrome
- Telitacicept
- +5 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 30, 2022
COVID-19, End Stage Renal Disease Trial in Copenhagen, Herlev, Hillerød (Hydroxychloroquine)
Withdrawn
- COVID-19
- End Stage Renal Disease
-
Copenhagen, Denmark
- +2 more
Nov 5, 2021
2019 Novel Coronavirus Trial in Amman (HCQ01, standard of care (SOC) for COVID-19)
Recruiting
- 2019 Novel Coronavirus
- HCQ01
- standard of care (SOC) for COVID-19
-
Amman, JordanPrince Hamza Hospital/ Amman Field Hospital
Mar 2, 2022
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 28, 2022
Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquin)
Recruiting
- Surfactant Dysfunction
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Mar 14, 2022
The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting
- Connective Tissue Diseases
- Pregnancy Related
- Prednisone
- +3 more
-
Jinan, Shandong, ChinaQilu Hospital
Sep 26, 2022
Healthy Participants, Rheumatoid Arthritis (RA) Prevention Trial in United States (Hydroxychloroquine, HCQ Placebo)
Completed
- Healthy Participants
- Rheumatoid Arthritis (RA) Prevention
- Hydroxychloroquine
- HCQ Placebo
-
Los Angeles, California
- +12 more
Dec 14, 2022
Covid19, COVID-19 Prevention Trial in Chandigarh (Hydroxychloroquine (HCQ), Standard care, Placebo)
Recruiting
- Covid19
- COVID-19 Prevention
- Hydroxychloroquine (HCQ)
- +2 more
-
Chandigarh, IndiaPost Graduate Institute of Medical Education and Research
Jun 8, 2021
Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,
Completed
- Systemic Lupus Erythematosus (SLE)
- +2 more
- Thalidomide
- +2 more
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)
Terminated
- Diabetes Mellitus Type 2 With Hyperglycemia
-
Los Angeles, CaliforniaCharles Drew University of Medicine and Science
Sep 23, 2022
Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +6 more
- (no location specified)
Dec 28, 2022
Retinitis Pigmentosa Trial in Ann Arbor (Hydroxychloroquine lower dose, Hydroxychloroquine higher dose)
Recruiting
- Retinitis Pigmentosa
- Hydroxychloroquine lower dose
- Hydroxychloroquine higher dose
-
Ann Arbor, MichiganUniversity of Michigan
Feb 14, 2022
Coronavirus, Corona Virus Infection Trial in New York (Group 1 HCQ, Group 2 Placebo)
Terminated
- Coronavirus
- Corona Virus Infection
- Group 1 HCQ
- Group 2 Placebo
-
New York, New YorkProHealth New York
Oct 15, 2021
Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)
Completed
- Advanced Adenocarcinoma
- Metastatic Adenocarcinoma
- Hydroxychloroquine (HCQ)
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 29, 2022